TherapeuticsMD, Inc. (NasdaqGS: TXMD)
Health Care · Pharmaceuticals · US
$2.02
-1.94% today · +96.2% 1Y
TherapeuticsMD, Inc. (NasdaqGS: TXMD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $23.84M and employs 1 people.
Over the last twelve months the share price has gained 96.2%, trading between 1.03 and 2.95.
Tweenvest scores TherapeuticsMD, Inc. across four factors: quality 66/100, value 55/100. Its strongest factor is quality.
TXMD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $23.84M
- Revenue (TTM)
- $3.27M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.65
- 52-week high
- $2.95
- 52-week low
- $1.03
- Avg volume (3M)
- —
- Shares outstanding
- 11.57M
- Employees
- 1
- Next earnings
- —
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17ß-estradiol and progesterone, used to alleviate moderate to severe vasomotor symptoms; and ANNOVERA, an innovative vaginal ring designed for contraception. In its developmental pipeline, TherapeuticsMD is advancing several preclinical candidates: TX-005HR, a transdermal cream containing only progesterone; TX-006HR, another transdermal cream formulated with both estradiol and progesterone; TX-007HR and TX-008HR, both experimental transdermal patches; and TX-009HR, an oral formulation of progesterone and estradiol. Beyond its core pharmaceutical offerings, the company produces and distributes both branded and generic prescription prenatal vitamins, notably under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 labels. Its prescription medications and prenatal vitamin lines reach consumers through established channels, including wholesale and retail pharmacy distributors. Established in 2008, TherapeuticsMD, Inc. maintains its corporate headquarters in Boca Raton, Florida.
- ISIN
- US88338N2062
- Founded
- 2008
- Listed since
- May 9, 2007
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Orexo AB (publ)OM: ORX | $24.32M | Skr6.19 | -5.93% |
| Everest Organics LimitedBSE: 524790 | $24.15M | Rs240.65 | +9.49% |
| Gennex Laboratories LimitedBSE: 531739 | $24.12M | Rs9.61 | -1.94% |
| PT Indofarma TbkIDX: INAF | $23.91M | Rp— | — |
| Quantum BioPharma Ltd.NasdaqCM: QNTM | $23.78M | $2.80 | -4.76% |
| Emyria LimitedASX: EMD | $23.64M | AU$0.04 | -6.67% |
| Kontafarma China Holdings LimitedSEHK: 1312 | $23.50M | HK$0.03 | +3.13% |
| Tdspharm Co., Ltd.KOSDAQ: A464280 | $22.99M | ₩5,590.00 | +3.71% |
Figures last refreshed Oct 11, 2026.